Core Viewpoint - The company, Lino Pharmaceutical Packaging, announced that its stock price has remained above 130% of the conversion price of its convertible bonds for ten consecutive trading days, potentially triggering a conditional redemption clause for the bonds [1] Group 1 - As of January 28, 2026, the company's stock price has closed at or above 18.46 CNY per share, which is 130% of the current conversion price of the convertible bonds [1] - If the stock price continues to meet this threshold, the company may consider redeeming the outstanding convertible bonds at face value plus accrued interest [1] - The board of directors will convene to decide on the redemption of all or part of the unconverted convertible bonds if the conditions are met [1]
力诺药包：关于“力诺转债”预计触发赎回条件的提示性公告